Renal cancer management is challenging from diagnosis to treatment and follow-up. In
cases of small renal masses and cystic lesions the differential diagnosis of benign or …

Personalized treatment strategies for cancer frequently rely on the detection of genetic
alterations which are determined by molecular biology assays. Historically, these processes …

Rationale and Objectives The sequencing of the renal cell carcinoma (RCC) genome
identified several mutations with prognostic significance. Genomic analysis, collected in The …

New spatial molecular technologies are poised to transform our understanding and
treatment of urological cancers. By mapping the spatial molecular architecture of tumours …

Purpose Upfront knowledge of tumor growth rates of clear cell renal cell carcinoma in von
Hippel-Lindau syndrome (VHL) patients can allow for a more personalized approach to …

Background To investigate reliable associations between dynamic contrast-enhanced
magnetic resonance imaging (DCE-MRI) features and gene expression characteristics in …

Renal cell carcinoma (RCC) is one of the most commonly diagnosed cancers in the United
States. It accounts for approximately 4.0% of new cancers and 2.3% of cancer-specific …

BACKGROUND Hepatocellular carcinoma (HCC) is the most common primary liver
malignancy with a rising incidence worldwide. The prognosis of HCC patients after radical …

Background: While acknowledging the generally poor prognostic features of brain
metastases from renal cell carcinoma (BM RCC), it is important to be aware of the fact that …

Simple Summary The incidence of solid renal masses has been steadily increasing over the
past couple of decades. Most renal masses are now incidental findings on ultrasound or …